Treatment of hepatic encephalopathy: It's not lactulose

BMJ

Volumn 329, Issue 7457, 2004, Pages 112-

  Shawcross, Debbie L ^a   Jalan, Rajiv ^a  

^a Institute of Hepatology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; AMMONIA; BASE; DISACCHARIDE; ELECTROLYTE; LACTITOL; LACTULOSE; PLACEBO;

CLINICAL PRACTICE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONSTIPATION; DEHYDRATION; DISORDERS OF ACID BASE BALANCE; DRUG EFFECT; DRUG EFFICACY; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION; LETTER; METABOLISM; PARALLEL DESIGN; PRIORITY JOURNAL; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

GASTROINTESTINAL AGENTS; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; RANDOMIZED CONTROLLED TRIALS;

EID: 3142585251     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7457.112     Document Type: Letter

References (4)

1. Als-Nielsen B, Gluud L, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ 2004; 328: 1046–50. (1 May.)
2. Jalan R, Kapoor D. Reversal of diuretic-induced hepatic encephalopathy with infusion of albumin but not colloid. Clin Sci 2004; 106: 467–74.
3. Shawcross D, Davies N, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40: 247–54.
4. Olde Damink S, Jalan R, Deutz N, Redhead D, Dejong C, Hynd P, et al. The kidney plays a major role in the hyperammonemia seen after a simulated or actual upper gastrointestinal bleeding in patients with cirrhosis. Hepatology 2003; 37: 1277–85.